Comparison between Fabtech Technologies IPO and Medicap Healthcare IPO.
Fabtech Technologies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Medicap Healthcare IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Fabtech Technologies IPO | Medicap Healthcare IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Unistone Capital Pvt.Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Fabtech Technologies IPO is up to ₹230.30 Cr whereas the issue size of the Medicap Healthcare IPO is up to ₹240.00 Cr. The final issue price of Fabtech Technologies IPO is ₹191.00 per share and of Medicap Healthcare IPO is .
| Fabtech Technologies IPO | Medicap Healthcare IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹181.00 per share | |
| Issue Price (Upper) | ₹191.00 per share | |
| Issue Price (Final) | ₹191.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ₹9.00 per share | |
| Market Lot Size | 75 shares | |
| Fresh Issue Size | 1,20,58,555 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹230.30 Cr | up to ₹240.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,20,58,555 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹230.30 Cr | up to ₹240.00 Cr |
Fabtech Technologies IPO opens on Sep 29, 2025, while Medicap Healthcare IPO opens on . The closing date of Fabtech Technologies IPO and Medicap Healthcare IPO is Oct 01, 2025, and , respectively.
| Fabtech Technologies IPO | Medicap Healthcare IPO | |
|---|---|---|
| Anchor Bid Date | Sep 26, 2025 | |
| Issue Open | Sep 29, 2025 | |
| Issue Close | Oct 01, 2025 | |
| Basis Of Allotment (Tentative) | Oct 03, 2025 | |
| Initiation of Refunds (Tentative) | Oct 06, 2025 | |
| Credit of Share (Tentative) | Oct 06, 2025 | |
| Listing date (Tentative) | Oct 07, 2025 | |
| Anchor Lockin End date 1 | Nov 02, 2025 | |
| Anchor Lockin End date 2 | Jan 01, 2026 |
Fabtech Technologies IPO P/E ratio is 13.32, as compared to Medicap Healthcare IPO P/E ratio of .
| Fabtech Technologies IPO | Medicap Healthcare IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Fabtech Technologies Ltd.'s revenue increased by 46% and profit after tax (PAT) rose by 70% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Medicap Healthcare Ltd.'s revenue increased by 7% and profit after tax (PAT) rose by 11% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 94.60 | 98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.94 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.32 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹849.04 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 30.46% | 27.30% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.46% | 17.67% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.32 | 0.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹14.34 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 26.83% | 24.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Fabtech Technologies IPO Retail Individual Investors (RII) are offered 42,01,770 shares while in Medicap Healthcare IPO retail investors are offered 42,01,770 shares. Qualified Institutional Buyers (QIB) are offered 60,02,526 shares in Fabtech Technologies IPO and 0 shares in Medicap Healthcare IPO.
| Fabtech Technologies IPO | Medicap Healthcare IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 60,02,526 shares | 0 shares |
| NII | 18,00,759 shares | 0 shares |
| RII | 42,01,770 shares | 0 shares |
| Employee | 54,945 shares | 0 shares |
| Others | ||
| Total | 1,20,60,000 shares | 0 shares |
Fabtech Technologies IPO subscribed 2.04x in total, whereas Medicap Healthcare IPO subscribed .
| Fabtech Technologies IPO | Medicap Healthcare IPO | |
|---|---|---|
| QIB (times) | 2.02x | |
| NII (times) | 1.97x | |
| Big NII (times) | 1.65x | |
| Small NII (times) | 2.60x | |
| RII (times) | 2.09x | |
| Employee (times) | 2.01x | |
| Other (times) | ||
| Total (times) | 2.04x |
